DJIA 16,424.85 162.29 1.00%
NASDAQ 4,086.23 0.00 0.00%
S&P 500 1,862.31 19.33 1.05%
market minute promo

49.11 0.94 (1.95%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMY $49.11 1.95%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.42
Previous Close $48.17
Daily Range $48.41 - $49.21
52-Week Range $39.18 - $57.49
Market Cap $81.0B
P/E Ratio 31.28
Dividend (Yield) $1.44 (3.0%)
Ex-Dividend Date
Dividend Pay Date
04/02/14
05/01/14
Volume 7,649,940
Average Daily Volume 8,945,355
Current FY EPS $1.76

Sector

Healthcare

Industry

Drugs

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/

News & Commentary Rss Feed

ARIAD Pharmaceuticals, Inc. Battling Back

Since returning to market, ARIAD Pharmaceuticals has captured about half of the patients on Iclusig before it went off the market, but it'll have a hard time competing with Novartis' and Bristol-Myers Squibb's leukemia drugs.

3 Stocks Reiterated As A Buy: BMY, CELG, V

Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog

Portola's Betrixaban Study Design Published - Analyst Blog

Noteworthy ETF Inflows: XLV, JNJ, AMGN, BMY

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

UPDATE: Bristol-Myers Squibb Submits NDA to US FDA for Fixed-Dose Combo Tablet for Atazanavir Sulfat

UPDATE: Bristol-Myers Squibb Submits NDA to US FDA for Fixed-Dose Combo Tablet for Atazanavir Sulfate with Cobicistate

3 Stocks Reiterated As A Buy: BMY, LOW, CSCO

Encouraging Data from Bristol-Myers - Analyst Blog

Market Hustle: Stock Futures Flat Ahead of JPMorgan, Wells Fargo Earnings

See More BMY News...

BMY's Top Competitors

BMY $49.11 (1.95%)
Current stock: BMY
NVS $84.41 (0.74%)
Current stock: NVS
PFE $30.09 (0.67%)
Current stock: PFE
JNJ $98.75 (-0.45%)
Current stock: JNJ